TOSI, FEDERICA MARIA
 Distribuzione geografica
Continente #
EU - Europa 3.513
AS - Asia 2.481
NA - Nord America 2.204
SA - Sud America 256
AF - Africa 75
OC - Oceania 31
Totale 8.560
Nazione #
US - Stati Uniti d'America 2.060
DE - Germania 1.109
CN - Cina 908
IT - Italia 702
CH - Svizzera 473
SG - Singapore 470
GB - Regno Unito 263
BD - Bangladesh 205
VN - Vietnam 200
BR - Brasile 178
HK - Hong Kong 152
JP - Giappone 141
ES - Italia 131
IN - India 125
FR - Francia 121
SE - Svezia 115
RU - Federazione Russa 110
FI - Finlandia 99
CA - Canada 97
NL - Olanda 80
IE - Irlanda 64
DK - Danimarca 55
ID - Indonesia 45
TR - Turchia 36
MX - Messico 35
KR - Corea 33
PT - Portogallo 28
TW - Taiwan 28
AU - Australia 27
PL - Polonia 26
RO - Romania 25
AR - Argentina 24
AT - Austria 23
BE - Belgio 22
CI - Costa d'Avorio 21
IL - Israele 18
CO - Colombia 17
IQ - Iraq 15
PH - Filippine 15
GR - Grecia 13
CL - Cile 12
EC - Ecuador 12
ZA - Sudafrica 12
IR - Iran 10
PK - Pakistan 10
UA - Ucraina 10
EG - Egitto 9
NO - Norvegia 9
SA - Arabia Saudita 9
CZ - Repubblica Ceca 8
JO - Giordania 8
MA - Marocco 8
UZ - Uzbekistan 8
MY - Malesia 7
SC - Seychelles 7
TH - Thailandia 7
CY - Cipro 6
GN - Guinea 6
HU - Ungheria 5
SI - Slovenia 5
GE - Georgia 4
HR - Croazia 4
KZ - Kazakistan 4
NZ - Nuova Zelanda 4
OM - Oman 4
PY - Paraguay 4
RS - Serbia 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
LT - Lituania 3
TN - Tunisia 3
AM - Armenia 2
AZ - Azerbaigian 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
GY - Guiana 2
KE - Kenya 2
LB - Libano 2
LU - Lussemburgo 2
SD - Sudan 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
DZ - Algeria 1
ET - Etiopia 1
GF - Guiana Francese 1
HN - Honduras 1
LK - Sri Lanka 1
MT - Malta 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
Totale 8.558
Città #
Frankfurt am Main 969
Zurich 453
Ashburn 291
Singapore 249
Milan 204
Southend 171
Beijing 133
Hong Kong 123
Chandler 115
San Jose 106
Redwood City 98
Dallas 89
Council Bluffs 83
Helsinki 76
New York 71
Santa Clara 70
Los Angeles 67
Ho Chi Minh City 64
Dublin 59
Fairfield 59
Hefei 53
Rome 52
Guangzhou 49
Hanoi 48
Houston 44
Nanjing 41
Wilmington 41
Dearborn 38
Tokyo 38
Shanghai 37
Jakarta 34
Princeton 34
Phoenix 31
Buffalo 29
Bengaluru 27
Lauterbourg 27
Bar Harbor 26
Madrid 26
Moscow 25
Woodbridge 25
Cambridge 24
Ottawa 23
Boardman 22
Hangzhou 22
Jinan 22
Abidjan 21
Barcelona 20
Haiphong 19
São Paulo 19
Toronto 19
Chicago 18
Istanbul 18
Naples 18
Munich 17
Turin 17
Shenyang 16
Ann Arbor 15
Chengdu 15
Da Nang 15
Amsterdam 14
Atlanta 14
Changsha 14
Hyderabad 14
Montreal 14
Wuhan 14
Seattle 13
Tianjin 13
Uppsala 13
Bologna 12
Chennai 12
Des Moines 12
Fuzhou 12
Taipei 12
Schiffdorf 11
Vienna 11
Zhengzhou 11
Lappeenranta 10
The Dalles 10
Berlin 9
Biên Hòa 9
Cairo 9
Central District 9
Columbus 9
Hebei 9
London 9
Mumbai 9
Redmond 9
San Diego 9
Seoul 9
Sydney 9
Baghdad 8
Boston 8
Bucharest 8
Catania 8
Modena 8
Newark 8
Orem 8
Warsaw 8
Amman 7
Bordeaux 7
Totale 5.057
Nome #
Liquid biopsy for rectal cancer: a systematic review 1.722
Entrectinib for the treatment of metastatic NSCLC: safety and efficacy 867
The challenge of molecular selection in liver-limited metastatic colorectal cancer for surgical resection: a systematic review and meta-analysis in the context of current and future approaches 610
High Circulating Methylated DNA Is a Negative Predictive and Prognostic Marker in Metastatic Colorectal Cancer Patients Treated With Regorafenib 342
Strategies to tackle RAS-mutated metastatic colorectal cancer 305
Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer 289
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial 284
Pneumatosis Intestinalis Induced by Anticancer Treatment: A Systematic Review 271
Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA 266
The quest for improving treatment of cancer of unknown primary (CUP) through molecularly-driven treatments: a systematic review 259
Circulating tumor DNA to drive treatment in metastatic colorectal cancer 251
Efficacy of Retreatment with Oxaliplatin-Based Regimens in Metastatic Colorectal Cancer Patients: The RETROX-CRC Retrospective Study 244
TRKA expression and NTRK1 gene copy number across solid tumours 235
Chemotherapy-induced myasthenic crisis in thymoma treated with primary chemotherapy with curative intent on mechanical ventilation: a case report and review of the literature 233
Digital PCR assessment of MGMT promoter methylation coupled with reduced protein expression optimises prediction of response to alkylating agents in metastatic colorectal cancer patients 225
The evolutionary landscape of treatment for BRAFv600e mutant metastatic colorectal cancer 223
Clinicopathological characterisation of MTAP alterations in gastrointestinal cancers 214
Case Report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer 208
Retreatment with anti-EGFR monoclonal antibodies in metastatic colorectal cancer: Systematic review of different strategies 207
Oxaliplatin Immune-Induced Syndrome Occurs With Cumulative Administration and Rechallenge : Single Institution Series and Systematic Review Study 202
The evolving panorama of HER2-targeted treatments in metastatic urothelial cancer: A systematic review and future perspectives 197
Empowering clinical decision making in oligometastatic colorectal cancer: The potential role of drug screening of patient-derived organoids 190
Ongoing Clinical Trials and Future Research Scenarios of Circulating Tumor DNA for the Treatment of Metastatic Colorectal Cancer 185
Immunocytokines in cancer treatment: A systematic review 151
HER2 Positivity Predicts Unresponsiveness to EGFR-Targeted Treatment in Metastatic Colorectal Cancer 150
Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection : a Systematic Review and Meta-Analysis 126
Impact of chemotherapy on humoral and cellular immune responses to COVID-19 vaccination in patients with solid tumors 118
Tracking a CAD-ALK gene rearrangement in urine and blood of a colorectal cancer patient treated with an ALK inhibitor 107
Major adverse cardiovascular events associated with VEGF-targeted anticancer tyrosine kinase inhibitors: a real-life study and proposed algorithm for proactive management 93
Totale 8.774
Categoria #
all - tutte 19.891
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.891


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022797 76 63 63 99 93 52 75 52 74 35 38 77
2022/2023717 64 61 60 59 55 103 47 46 106 12 49 55
2023/20241.259 52 52 74 61 100 58 140 143 84 157 170 168
2024/20251.366 158 155 125 152 75 64 63 96 84 110 94 190
2025/20263.077 236 192 452 394 211 130 387 107 209 196 359 204
2026/2027129 129 0 0 0 0 0 0 0 0 0 0 0
Totale 8.774